Interhospital transports and mortality in patients with critical COVID-19: a single-centre cohort study

被引:0
|
作者
Agegard, Lina Toss [1 ]
Berggren, Karin [1 ,2 ]
Cronhjort, Maria [2 ,3 ]
Joelsson-Alm, Eva [1 ,2 ]
Sackey, Peter [4 ]
Jonmarker, Sandra [1 ,2 ]
Schandl, Anna Regina [1 ,2 ]
机构
[1] Soder Sjukhuset, Dept Perioperat & Intens Care, Stockholm, Sweden
[2] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden
[3] Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden
[4] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
来源
BMJ OPEN | 2025年 / 15卷 / 02期
关键词
COVID-19; Adult intensive & critical care; Safety; SEPSIS;
D O I
10.1136/bmjopen-2024-090952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aimed to compare mortality rates and length of hospital stay between patients with critical COVID-19 transferred to another hospital due to capacity constraints and those who remained at their initial admission hospital. Design Single-centre cohort study. Setting and participants 665 patients were treated for SARS-CoV-2 at two intensive care units (ICUs) in Stockholm, Sweden, from 1 March 2020 to 30 June 2021. Data on interhospital transfers (IHTs) were retrieved from medical records and patient data management systems according to predefined protocols. Main outcome measures The outcomes were 30-day and 90-day mortality, days alive and out of ICU. HR with 95% CI were calculated using Cox proportional hazard models with adjustments for age, sex, body mass index, severity of illness, comorbidity, invasive ventilation, treatment limitations and pandemic waves. Results Of 665 patients, 133 (20%) were transferred to another hospital. The mortality rate of transferred patients compared with non-transferred patients at 30 days was 19% vs 26% (p=0.13) and at 90 days 26% vs 30% (p=0.43). In the adjusted Cox regression analysis, IHT was associated with a lower mortality risk at 30 days (HR 0.47, 95% CI 0.30 to 0.76) and 90 days (HR 0.52, 95% CI 0.34 to 0.79). However, the number of days alive and out of ICU was significantly lower for the IHT group at 30 days. Conclusion In our study, IHT due to capacity constraints among critically ill COVID-19 patients was not associated with a higher mortality risk. The suitability for transfer was likely associated with lower mortality, although residual confounding cannot be ruled out. The requirement for invasive ventilation among transferred patients might account for the extended length of ICU stay, rather than the transfer itself. However, the difficulty in studying this issue lies in the fact that while patients are likely exposed to risks during transfer, they are simultaneously the patients stable enough to be transported.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study
    Mas-Ubillus, Guiliana
    Ortiz, Pedro J.
    Huaringa-Marcelo, Jorge
    Sarzo-Miranda, Paola
    Munoz-Aguirre, Patricia
    Diaz-Ramos, Alejandra
    Arribasplata-Purizaca, Kattia
    Mendoza, Doris
    Rojas-Poma, Juan
    Marcelo-Ruiz, Cristian
    Ayala-Diaz, Pedro
    Hidalgo-Arroyo, Edwin
    Tupia-Cespedes, Lourdes
    PLOS ONE, 2022, 17 (03):
  • [42] Spontaneous pneumothorax associated with COVID-19 pneumonia: a single-centre retrospective study
    Hadzhiminev, Velizar D.
    Paunov, Lybomir
    Dimcheva, Teodora
    Uchikov, Angel
    Novakov, Ivan
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (01)
  • [43] Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
    San-Juan, Rafael
    Barbero, Patricia
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Lizasoain, Manuel
    Hernandez-Jimenez, Pilar
    Silva, Jose Tiago
    Ruiz-Ruigomez, Maria
    Corbella, Laura
    Rodriguez-Goncer, Isabel
    Folgueira, Maria Dolores
    Lalueza, Antonio
    Batllori, Emma
    Mejia, Inma
    Forcen, Laura
    Lumbreras, Carlos
    Garcia-Burguillo, Antonio
    Galindo, Alberto
    Aguado, Jose Maria
    ECLINICALMEDICINE, 2020, 23
  • [44] Risk stratification and prognosis prediction using cardiac biomarkers in COVID-19: a single-centre retrospective cohort study
    Sano, Madoka
    Toyota, Toshiaki
    Morimoto, Takeshi
    Noguchi, Yu
    Shigeno, Ryo
    Murai, Ryosuke
    Okada, Taiji
    Sasaki, Yasuhiro
    Taniguchi, Tomohiko
    Kim, Kitae
    Kobori, Atsushi
    Ehara, Natsuhiko
    Kinoshita, Makoto
    Doi, Asako
    Tomii, Keisuke
    Kihara, Yasuki
    Furukawa, Yutaka
    BMJ OPEN, 2024, 14 (04):
  • [45] Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain
    San-Juan, Rafael
    Barbero, Patricia
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Lizasoain, Manuel
    Hernandez-Jimenez, Pilar
    Silva, Jose Tiago
    Ruiz-Ruigomez, Maria
    Corbella, Laura
    Rodriguez-Goncer, Isabel
    Folgueira, Maria Dolores
    Lalueza, Antonio
    Batllori, Emma
    Mejia, Inma
    Forcen, Laura
    Lumbreras, Carlos
    Garcia-Burguillo, Antonio
    Galindo, Alberto
    Aguado, Jose Maria
    ECLINICALMEDICINE, 2020, 23
  • [46] Maternal and Neonatal Outcomes of COVID-19 in Pregnancy: A Single-Centre Observational Study
    Singh, Vinita
    Choudhary, Anisha
    Datta, Mamta R.
    Ray, Alokananda
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [47] Impact of COVID-19 on training: a single-centre survey of trainees
    Whitby, Thomas
    Cleary, Gavin
    Halfhide, Clare P.
    BMJ PAEDIATRICS OPEN, 2020, 4 (01)
  • [48] Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo
    Latifi-Pupovci, Hatixhe
    Namani, Sadie
    Ahmetaj-Shala, Blerina
    Pajaziti, Artina
    Bunjaku, Gramoz
    Ajazaj Berisha, Lindita
    Gegaj, Valentin
    Kotori, Afrim
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [49] Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study
    Federico Montini
    Agostino Nozzolillo
    Paola M. V. Rancoita
    Chiara Zanetta
    Lucia Moiola
    Federica Cugnata
    Federica Esposito
    Maria A. Rocca
    Vittorio Martinelli
    Massimo Filippi
    Journal of Neurology, 2023, 270 : 1835 - 1842
  • [50] Effects of traditional Chinese medicine on treatment outcomes in severe COVID-19 patients: a single-centre study
    XIAO Yongjiu
    LI Binbin
    LIU Chang
    HUANG Xiuyu
    MA Ling
    QIAN Zhirong
    ZHANG Xiaopeng
    ZHANG Qian
    LI Dunqing
    CAI Xiaoqing
    YAN Xiangyong
    LUO Shuping
    XIANG Dawei
    XIAO Kun
    Chinese Journal of Natural Medicines, 2024, 22 (01) : 89 - 96